CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call
MINNEAPOLIS, March 16, 2023 -- CVRx, Inc. , a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular... | March 16, 2023
Source: marketscreener.com